| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 324,494 | 372,526 | 390,578 | 346,153 | | Cost of Revenue | 146,499 | 165,057 | 178,405 | 161,557 | | | Gross Profit | 177,995 | 207,469 | 212,173 | 184,596 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 76,755 | 96,129 | 118,328 | 84,670 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 101,240 | 111,340 | 93,845 | 99,926 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 425 | 478 | (503) | 705 | | Earnings Before Interest And Taxes | 101,665 | 111,818 | 93,342 | 100,631 | | Interest Expense | 16,677 | 16,957 | 16,741 | 24,447 | | Income Before Tax | 84,988 | 94,861 | 76,601 | 76,184 | | Income Tax Expense | 33,040 | 36,900 | 29,796 | 29,350 | | Minority Interest | 1,923 |
-
|
-
| 822 | | | | Net Income From Continuing Ops | 53,871 | 57,961 | 46,805 | 47,656 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,871 | 57,961 | 46,805 | 47,656 | | Preferred Stock And Other Adjustments | (1,302) | 801 | 501 |
-
| | | Net Income Applicable To Common Shares | $52,569 | $58,762 | $47,306 | $47,656 |
|
0.22% Nasdaq 
Income Statement
